Financial Performance - Total revenue for the year ended December 31, 2025, was HKD 54,309,000, representing an increase from HKD 53,010,000 in 2024, which is a growth of approximately 2.4%[4] - Gross profit decreased to HKD 30,447,000 in 2025 from HKD 31,698,000 in 2024, reflecting a decline of about 3.9%[4] - The net loss attributable to equity holders of the company for 2025 was HKD 3,866,000, compared to a loss of HKD 807,000 in 2024, indicating a significant increase in losses[4] - The group reported a net loss of HKD 249,000 for 2025, compared to a profit of HKD 2,871,000 in 2024, marking a significant decline[34] - The company reported a basic and diluted loss per share of HKD 0.59 for 2025, compared to HKD 0.12 in 2024, indicating a worsening financial position[5] Assets and Liabilities - Total assets decreased to HKD 99,560,000 in 2025 from HKD 113,445,000 in 2024, a reduction of approximately 12.2%[6] - Total liabilities decreased to HKD 52,481,000 in 2025 from HKD 67,766,000 in 2024, a decline of about 22.5%[7] - Non-current assets totaled HKD 30,796,000 in 2025, down from HKD 39,336,000 in 2024, reflecting a decrease of approximately 21.7%[6] - The group's debt is approximately HKD 21.64 million as of December 31, 2025, compared to HKD 31.11 million on December 31, 2024, resulting in a leverage ratio of about 21.73%[65] - The net current assets are approximately HKD 23.46 million as of December 31, 2025, with a current ratio of about 1.52, up from 1.30 on December 31, 2024[65] Revenue Segmentation - Healthcare and medical business revenue reached HKD 48,353,000 in 2025, up from HKD 39,705,000 in 2024, reflecting a growth of approximately 21%[24] - Beauty and wellness business revenue decreased to HKD 5,956,000 in 2025 from HKD 13,305,000 in 2024, representing a decline of about 55%[24] - The healthcare and medical segment includes operations related to blood dialysis centers and hospitals[22] - The beauty and wellness segment focuses on the sale of beauty and wellness products and related services[22] Operational Changes - The group operates primarily in Hong Kong and the People's Republic of China, with business segments organized by the nature of operations and products or services offered[20] - The healthcare and medical business segment saw revenue growth due to increased capacity from relocating one of its hospitals[46] - The beauty and fitness business continued to incur losses, prompting the company to consider closing or selling its beauty clinics to mitigate further losses[48] Financial Management - Cash and cash equivalents at year-end were HKD 60,895,000, down from HKD 63,463,000 in 2024, a decrease of approximately 4.0%[6] - Trade receivables increased to HKD 3,593,000 in 2025 from HKD 3,441,000 in 2024, with a general credit period of 90 days[39] - Trade payables decreased significantly to HKD 2,183,000 in 2025 from HKD 4,041,000 in 2024, reflecting improved cash flow management[41] - Financing costs decreased to HKD 885,000 in 2025 from HKD 1,688,000 in 2024, a reduction of approximately 47.5%[33] - The group incurred a loss of HKD 206,000 in expected credit loss provisions for other receivables in 2025, down from HKD 435,000 in 2024, indicating an improvement[34] Corporate Governance - The board of directors has been identified as the primary decision-maker for the group, ensuring alignment in operational strategy and risk management[20] - The company has appointed a new independent non-executive director, effective July 1, 2025, to ensure compliance with corporate governance rules[85] - The audit committee consists of three independent non-executive directors, with one member possessing recognized accounting qualifications[88] - The company has established an internal audit function with the assistance of an external consultant to enhance risk management and internal controls[86] Compliance and Reporting - The group has adopted revised Hong Kong Financial Reporting Standards, which are not expected to have a significant impact on the financial position or performance of the group[14] - The financial statements for the year have been reviewed by the audit committee and are deemed to comply with applicable accounting standards[88] - The financial figures in the preliminary results announcement have been confirmed by the auditors as consistent with the audited financial statements[89] - The annual performance announcement has been published on the Hong Kong Stock Exchange and the company's website, with the 2025 annual report to be sent to shareholders by April 30, 2026[90] Dividends and Share Capital - The company did not declare any dividends for the fiscal year ending December 31, 2025, consistent with the previous year[38] - The company maintained a stable issued share capital of 659,894,693 shares for both 2025 and 2024, with a par value of HKD 0.20[44] Asset Sales and Transactions - The company has completed the sale of two beauty salons in Shenzhen for a total cash consideration of RMB 1,980,000 (approximately HKD 2,250,000)[81] - The sale of the salons includes the transfer of store assets and liabilities, effective from September 2025 and October 2025[81] - The transactions are classified as discloseable transactions under the listing rules, as the percentage ratio exceeds 5% but is below 25%[81] Employee and Resource Management - The group employed 122 employees in Hong Kong and China as of December 31, 2025[79] - The company plans to utilize the remaining HKD 42.4 million from the 2020 rights issue for management expenses if suitable acquisition targets are not identified[64]

香 港 交易 及 結 算 所 有限 公 司 及 香港 聯 合 交 易 所有 限 公 司 對 本公 告 之 內 容概 不 負 責， 對 其 準 確 性或 完 整 性 亦不 發 表 任 何 聲明 ， 並 明 確 表示 概 不 就 因本 公 告 全部 或 任 何 部 分內 容 而 產 生或 因 倚 賴 該 等內 容 而 引 致 之任 何 損 失 承擔 任何責任。 董 事 會 謹 此 宣 佈 ， 於 2026 年 3 月 17 日 ， 賣 方（ 本 公 司 間 接 擁 有 51% 權 益 之 附屬公司 ）：(a)與第一買方就出售第一美容院訂立第一份出售協議，現金 代 價 為 人 民 幣 1,410,000 元（ 1,602,000 港 元 ）； 及 (b) 與 第 二 買 方 就 出 售 第 二 美 容 院 訂 立 第 二 份 出 售 協 議 ， 現 金 代 價 為 人 民 幣 570,000 元（ 648,000 港 元 ）。 GREEN INTERNATIONAL HOLDINGS LIMITED 格 林 國 際 控 股 有 限 公 司 由 於 按 單 獨 基 準 計 算 之 有 關 第 一 項 及 第 二 項 ...

董事會會議日期 格林國際控股有限公司（「本公司」）董事（「董事」）會（「董事會」）謹此宣佈， 本 公 司 謹 訂 於 2026 年 3 月 31 日 假 座 香 港 干 諾 道 中 200 號 信 德 中 心 西 座 17 樓 1708室舉行董事會會議，藉以（ 其中包括 ）考慮及批准本公司及其附屬公司 截 至 2025 年 12 月 31 日 止 年 度 之 全 年 業 績 及 考 慮 派 付 末 期 股 息（ 如 有 ）的 建 議。 承董事會命 格林國際控股有限公司 主席 香 港 交易 及 結 算 所 有限 公 司 及 香港 聯 合 交 易 所有 限 公 司 對 本公 告 之 內 容概 不 負 責， 對 其 準 確 性或 完 整 性 亦不 發 表 任 何 聲明 ， 並 明 確 表示 概 不 就 因本 公 告 全部 或 任 何 部 分內 容 而 產 生或 因 倚 賴 該 等內 容 而 引 致 之任 何 損 失 承擔 任何責任。 GREEN INTERNATIONAL HOLDINGS LIMITED 格 林 國 際 控 股 有 限 公 司 （ 於開曼群島註冊成立之有限公司 ） （股份代號：2700） 俞周杰 ...

截至月份: 2026年2月28日 狀態: 新提交 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致：香港交易及結算所有限公司 公司名稱: 格林國際控股有限公司 呈交日期: 2026年3月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02700 | 說明 | N/A | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | 本月底法定/ ...

Core Viewpoint - The Hong Kong stock market in early 2026 is heavily focused on AI IPOs, with HaiZhi Technology (02706) experiencing a significant surge in its stock price, indicating strong market interest and potential for growth [1] Group 1: Market Dynamics - The AI IPOs have become a central theme for capital chasing, with HaiZhi Technology's first-day increase of 242.2% and subsequent gains of 29.6% and 28.4% on the following days [1] - The market's enthusiasm is driven by retail investors attracted to the "AI de-illusion" niche, while institutional investors recognize the strategic value of investing in HaiZhi Technology [1][4] Group 2: Strategic Positioning - HaiZhi Technology has positioned itself uniquely by identifying the core contradictions in the large model industry's application, focusing on vertical integration rather than following the general model trend [3] - The company’s Atlas AI system is compatible with over 100 large language models, enhancing its adaptability and market reach [3] Group 3: Competitive Advantages - HaiZhi Technology has established a strong customer retention rate of 92% for its government clients, indicating high customer loyalty and significant switching costs for clients [3] - The company has built a robust client base, with over 360 government and enterprise clients, which provides a solid foundation for future growth [11] Group 4: Technological Edge - The company has developed a unique technology stack in knowledge graphs and graph computing, which is difficult for competitors to replicate [5] - HaiZhi Technology's approach aligns closely with global leaders like Palantir, focusing on building enterprise decision-making systems through graph-based methodologies [5][7] Group 5: Financial Performance - HaiZhi Technology's revenue for 2024 is projected to reach 5.03 billion RMB, significantly outperforming competitors like MiniMax and Zhipu AI [11] - The company has achieved a compound annual growth rate of 26.8% from 2022 to 2024, with a remarkable revenue growth of 872.2% for its core Atlas AI product in 2024 [11] Group 6: Market Valuation - Current market valuations suggest that HaiZhi Technology is significantly undervalued compared to its peers, with potential for a market capitalization exceeding 100 billion RMB [12][15] - Analysts predict that the company's market value could approach 120 billion RMB by the end of 2026, driven by its strong positioning in the B2B AI application market [15]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 格林國際控股有限公司 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02700 | 說明 | N/A | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | 本月底法定/ ...

公司名稱: 格林國際控股有限公司 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02700 | 說明 | N/A | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | 本月底法定/註冊股本總額： HKD 200,000,000 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 格林國際控股有限公司 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02700 | 說明 | N/A | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | | 0.2 HKD | | 200,000,000 | 本月底法 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 格林國際控股有限公司 呈交日期: 2025年11月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02700 | 說明 | N/A | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | 本月底法 ...

截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 格林國際控股有限公司 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02700 | 說明 | N/A | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 1,000,000,000 | HKD | | 0.2 | HKD | | 200,000,000 | 本月底法定 ...